ROZZINI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 6.879
AS - Asia 3.151
EU - Europa 3.138
SA - Sud America 661
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 13.890
Nazione #
US - Stati Uniti d'America 6.782
CN - Cina 1.209
SG - Singapore 975
UA - Ucraina 845
BR - Brasile 545
PL - Polonia 516
DE - Germania 490
HK - Hong Kong 400
IT - Italia 388
FI - Finlandia 223
VN - Vietnam 190
GB - Regno Unito 172
RU - Federazione Russa 136
IE - Irlanda 119
TR - Turchia 115
FR - Francia 108
IN - India 90
CA - Canada 47
AR - Argentina 46
BD - Bangladesh 37
MX - Messico 32
SE - Svezia 24
IQ - Iraq 20
ZA - Sudafrica 20
AT - Austria 19
BE - Belgio 19
JP - Giappone 18
EC - Ecuador 17
ID - Indonesia 17
IR - Iran 17
NL - Olanda 17
VE - Venezuela 12
CO - Colombia 11
MA - Marocco 11
PY - Paraguay 10
ES - Italia 9
PK - Pakistan 9
UZ - Uzbekistan 9
CH - Svizzera 8
CL - Cile 7
CZ - Repubblica Ceca 7
EU - Europa 7
LT - Lituania 7
AU - Australia 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
JO - Giordania 5
KR - Corea 5
PE - Perù 5
SA - Arabia Saudita 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
LV - Lettonia 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
MU - Mauritius 3
MY - Malesia 3
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
SI - Slovenia 2
BB - Barbados 1
BJ - Benin 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 13.889
Città #
Fairfield 974
Woodbridge 791
Jacksonville 556
Ashburn 541
Warsaw 516
Houston 503
Singapore 456
Hong Kong 399
Wilmington 375
Cambridge 363
Seattle 361
Ann Arbor 307
Beijing 255
Princeton 221
Nanjing 219
Chandler 208
New York 149
Dublin 119
Brescia 115
Los Angeles 108
Istanbul 103
Helsinki 98
Munich 92
Nanchang 72
Ho Chi Minh City 65
Hebei 55
Milan 54
Buffalo 53
The Dalles 51
Des Moines 49
Moscow 47
San Diego 45
Dearborn 44
São Paulo 44
Changsha 43
Shanghai 43
Dallas 41
Jinan 41
Tianjin 41
Shenyang 38
Redondo Beach 37
San Francisco 36
Hanoi 33
Nuremberg 27
Jiaxing 26
Turku 25
Hangzhou 24
Kunming 23
Dong Ket 22
Chicago 20
Verona 20
Brussels 19
Toronto 19
London 18
Zhengzhou 18
Santa Clara 17
San Mateo 16
Boardman 15
Guangzhou 15
Montreal 15
Ningbo 15
Rio de Janeiro 15
Augusta 14
Lanzhou 14
Ardabil 13
Denver 13
Poplar 13
Brooklyn 12
Phoenix 12
Belo Horizonte 11
Charlotte 11
Mumbai 11
Tokyo 11
Boston 10
Chennai 10
Haikou 10
Johannesburg 10
Leawood 10
Stockholm 10
Jakarta 9
Salò 9
Tashkent 9
Thái Bình 9
Da Nang 8
Erbil 8
Fortaleza 8
Frankfurt am Main 8
Goiânia 8
Mexico City 8
Norwalk 8
Osasco 8
Vienna 8
Amsterdam 7
Falkenstein 7
Hải Dương 7
Monmouth Junction 7
Rome 7
Taiyuan 7
Washington 7
Auburn Hills 6
Totale 9.488
Nome #
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. 293
Gene expression profile in fibroblasts of Huntington's disease patients and controls 252
Behavioral disorders in Alzheimer disease: a transcultural perspective 249
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 238
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 231
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 215
COVID-19 impact on consecutive neurological patients admitted to the emergency department 209
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 190
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 189
Gene expression profile in fibroblasts of Huntington's disease patients and controls. 185
A case report: doctor, my daughter has Alzheimer's disease. 180
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 179
The Italian version of the pain assessment in advanced dementia (PAINAD) scale 174
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 172
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 169
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. 166
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 165
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 165
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 159
Cognitive dysfunction and age-related macular degeneration. 157
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 153
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 151
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 151
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 150
Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. 149
Gene expression profile in fibroblasts of Huntington's disease patients and controls 148
Alzheimer disease and frontotemporal dementia. 147
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 146
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 144
The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice 144
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. 143
Anxiety symptoms in mild cognitive impairment. 142
Depressive disorders in dementia. 142
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 141
Predictors of progression from mild cognitive impairment to Alzheimer disease. 141
Free copper in serum: An analytical challenge and its possible applications 137
Behavioral syndromes in Alzheimer's disease: description and correlates. 135
Does reversible MCI exist? 134
Does age at observation time affect the clinical presentation of mild cognitive impairment? 133
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 132
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 131
Do vascular risk factors play a role in the progression of mild cognitive impairment? 130
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment 129
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 126
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. 126
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 126
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 125
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 125
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. 124
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. 121
The migraine-PFO connection is independent of sex. 119
Object and action naming in Alzheimer's disease and frontotemporal dementia 118
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 118
Microvascular damage and platelet abnormalities in early Alzheimer's disease. 117
Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. 116
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 115
Transient global amnesia and venous flow patterns. 115
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 115
Surface dyslexia in an Italian patient with semantic dementia 115
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. 114
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. 113
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. 112
Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients 112
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 111
Alteration of APP processing in platelets and CSF of AD patients European 111
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 111
Transient global amnesia: a clinical and sonographic study 108
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 106
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. 105
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. 104
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 104
Transient global amnesia and disturbance of venous flow patterns 104
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. 102
Parkinsonian signs in subjects with mild cognitive impairment 102
Volume reduction in cerebral blood flow in patients with Alzheimer’s disease. A sonographic study 102
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 102
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 101
App isoforms ratio in platelets: A peripheral marker for the diagnosis and treatment of Alzheimer's disease? 101
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 101
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. 98
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 98
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 95
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 94
Aspetti etici delle demenze 93
Clinical correlates of executive dysfunctions in mild cognitive impairment 93
Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. 92
Apolipoprotein E allele and platelets amyloid precursor protein in Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors treatment 91
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study 88
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 83
Vascular risk factors for VaD and AD in a population-based prospective cohort. The PAQUID study 79
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 79
Retrograde jugular venous flow is a predisposing factor in transient global amnesia. 76
Short-term memory binding in mild cognitive impairment: a preclinical marker of Alzheimer's disease? 76
Predictors of recurence in paradoxical cerebral embolism 75
La depressione dell'anziano: un rilevante fattore di modulazione prognostica 75
L’Istituto di Riabilitazione Geriatrica (IDRG): un modello clinico-assistenziale per le demenze? 72
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 71
Il progetto Cronos e le Unità di Valutazione Alzheime 71
Hypercholesterolaemia increases platelet amyloid precusor protein processing impairment in Alzheimer's disease patients 71
Rehabilitation units for people suffering dementia. Reports on the development process for providing a model of care 70
Totale 12.977
Categoria #
all - tutte 63.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.263 0 0 0 0 0 242 76 250 210 172 242 71
2021/2022859 39 198 9 39 7 36 53 56 50 101 55 216
2022/2023691 129 21 12 35 65 207 6 61 91 4 25 35
2023/2024740 48 25 73 43 21 123 29 26 213 13 9 117
2024/20251.963 10 22 22 268 239 169 222 53 213 117 402 226
2025/20262.267 355 551 315 638 354 54 0 0 0 0 0 0
Totale 14.063